TTUHSC School of Pharmacy
HomeSOPFaculty & Staff Directory

Faculty & Staff Details

Profile for Steven Pass, PharmD

Steven Pass

Steven Pass, PharmD

  • Professor
  • PGY-2 Critical Care Residency Program Director
  • Vice Chair for Residency Programs
Office Phone: 214-358-9054
Mail Address: 4500 S. Lancaster Road, Bldg 7, R#119-A
Dallas TX 75216


Steven Pass, PharmD, FCCM, FCCP, FASHP, BCPS is a Professor and Vice Chair for Residency Programs at the Texas Tech University Health Sciences Center School of Pharmacy. He is a graduate of the University of Kentucky College of Pharmacy, and completed a Pharmacy Practice Residency at Baptist Memorial Hospital in Memphis, Tennessee, and a Critical Care Pharmacy Practice Residency at University Hospital in Cincinnati, Ohio. He maintains an active practice in the Medical ICU at the North Texas VA Health Care System, where he serves as a mentor for students and pharmacy residents. His areas of focus within the ICU are in the diagnosis and treatment of ventilator associated pneumonia, the timing of anti-microbials, and the therapy of sepsis. Through his involvement in numerous professional organizations, including ASHP, ACCP, AACP, TSHP, and the Society of Critical Care Medicine (SCCM), he has become a national leader in critical care pharmacy and a respected adviser in the area of resident education. In recognition of his work in critical care, he has been elected as a fellow of the American College of Critical Care Medicine, the American College of Clinical Pharmacy, and the American Society of Health-System Pharmacists.

Research Interests

ICU infections, ACLS, ventilator associated pneumonia, clinical toxicology, and post-graduate residency training

Selected Publications:

  • Clifford K, Dy-Boarman EA, Haase KK, Maxvill K, Pass SE, Alvarez CA. Challenges with Diagnosing and Managing Sepsis in Older Adults.. Expert review of anti-infective therapy 2016;:1-11.
  • Griffiths C, Pass SE, Yarbrough WC. Assessment of the intensive care unit treatment of pneumonia at a veterans affairs facility.. Hospital pharmacy 2014;49(10):950-5.
  • Gibson CM, Pass SE. Enteral naloxone for the treatment of opioid-induced constipation in the medical intensive care unit.. Journal of critical care 2014;29(5):803-7.
  • Dubey D, Sharma VD, Pass SE, Sawhney A, Stüve O. Para-dichlorobenzene toxicity - a review of potential neurotoxic manifestations.. Therapeutic advances in neurological disorders 2014;7(3):177-87.
  • Chen C, Pass SE. Risk factors for and impact of methicillin-resistant Staphylococcus aureus nasal colonization in patients in a medical intensive care unit.. American journal of infection control 2013;41(11):1100-1.